EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Early Video-assisted Thoracoscopic Surgery versus Tube Thoracostomy in Stage II (Fibrinopurulent) Pediatric Empyema: A Randomized Controlled Trial

Abhishek V. Kulkarni, Sheetal Upreti, Raghav Narang, Sujoy Neogi, Simmi K. Ratan

Journal of Indian Association of Pediatric Surgeons · 2026-11 · 31 (6) · 917-922

DOI: 10.4103/jiaps.jiaps_210_26 ↗
AbstractBibliografische Angaben

Abstract

A BSTRACT Background: Empyema thoracis remains a significant complication of pediatric pneumonia, associated with substantial morbidity. While tube thoracostomy is widely used as first-line treatment, early video-assisted thoracoscopic surgery (VATS) has emerged as a minimally invasive alternative with promising outcomes. Objective: The objective of the study was to compare clinico-radiological outcomes of early VATS versus tube thoracostomy in children with empyema and assess long-term pulmonary recovery. Materials and Methods: A randomized controlled trial was conducted over 18 months, including 44 children (≤12 years) with empyema thoracis. Patients were randomized into early VATS ( n = 22) and tube thoracostomy ( n = 22) groups. Outcomes included symptom resolution, duration of intercostal drainage, antibiotic therapy, hospital stay, radiological resolution, and pulmonary function. Results: Baseline characteristics were comparable. Early VATS resulted in significantly faster fever resolution (1.73 vs. 10.27 days, P < 0.001), shorter chest drain duration (5.10 vs. 22.36 days, P < 0.001), reduced antibiotic requirement, and shorter hospital stay (19.41 vs. 25.41 days, P < 0.01). Radiological and functional outcomes at 6 months were similar in both groups. Conclusion: Early VATS provides superior short-term outcomes without compromising long-term recovery and should be considered the preferred treatment modality to reduce acute morbidity, drainage duration, antibiotic exposure, and hospital stay in Stage II (fibrinopurulent) pediatric empyema. This short-term advantage is clinically significant in its own right, translating into reduced morbidity for children and lower burden on the healthcare system.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →